What New Prior Authorization Metrics Mean for Clinical Labs
KFF looks into payer claims denials, which continue to be scrutinized
KFF looks into payer claims denials, which continue to be scrutinized
However, attorney Danielle Sloane urges labs to be proactive about potential PAMA reporting requirements on Jan. 31 if the bill doesn’t pass quickly
Better clinical laboratory test data reporting would allow ‘Medicare rates to be more appropriately set,’ says Susan Van Meter
With new modifications to HIPAA potentially on the horizon, we hear from experts on HHS’ proposal
Bill that ended government shutdown includes provision to hold off PAMA cuts
How clinical laboratories should prepare for the next wave of oversight in the new year
However, clinical laboratories may have more say in future laws and guidance thanks to 2024 decision
However, a proposed bill called the RESULTS Act is racing to thwart the cuts to lab test reimbursement rates
Government reform and payer streamlining may reduce the burden on healthcare providers, but laboratories should remain vigilant
How the 2024 proposal will fare on Capitol Hill in 2025 remains to be seen, though
With the rule recently struck down by a Texas court, how should employers, including labs, handle such agreements going forward?